BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16207105)

  • 21. Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remission.
    Tallman MS; Pérez WS; Lazarus HM; Gale RP; Maziarz RT; Rowe JM; Marks DI; Cahn JY; Bashey A; Bishop MR; Christiansen N; Frankel SR; García JJ; Ilhan O; Laughlin MJ; Liesveld J; Linker C; Litzow MR; Luger S; McCarthy PL; Milone GA; Pavlovsky S; Phillips GL; Russell JA; Saez RA; Schiller G; Sierra J; Weiner RS; Zander AR; Zhang MJ; Keating A; Weisdorf DJ; Horowitz MM
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):204-16. PubMed ID: 16443518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Erythroleukemia in pregnancy with successful outcome of delivery].
    Tomizuka H; Yatabe M; Okudera K; Hatake K; Miwa T; Sakamoto S; Miura Y; Eguti M
    Rinsho Ketsueki; 1992 Feb; 33(2):194-9. PubMed ID: 1635168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute myeloid leukemia during pregnancy.
    Chang A; Patel S
    Ann Pharmacother; 2015 Jan; 49(1):48-68. PubMed ID: 25258419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful pregnancy in a woman with acute myeloid leukemia treated with high-dose whole-body irradiation.
    Chao HT; Wang PH; Yuan CC; Lee WL
    J Reprod Med; 1998 Aug; 43(8):703-6. PubMed ID: 9749425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relapse of acute lymphoblastic leukemia in pregnancy: survival following chemoirradiation and autologous transfer of interleukin-2-activated stem cells.
    Tewari K; Cappuccini F; Rosen RB; Rosenthal J; Asrat T; Kohler MF
    Gynecol Oncol; 1999 Jul; 74(1):143-6. PubMed ID: 10385569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S; Sakamaki H; Ohtake S; Emi N; Yagasaki F; Mitani K; Matsuda S; Kishimoto Y; Miyazaki Y; Asou N; Matsushima T; Takahashi M; Ogawa Y; Honda S; Ohno R;
    Cancer; 2005 Dec; 104(12):2726-34. PubMed ID: 16284985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant.
    van Dongen JC; Dalinghaus M; Kroon AA; de Vries AC; van den Heuvel-Eibrink MM
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):853-4. PubMed ID: 19779381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute myeloblastic leukemia during pregnancy].
    Radosević-Radojković N; Bosković D; Lazarević B; Elezović I; Tomashević R; Rolović Z
    Srp Arh Celok Lek; 1995; 123(3-4):96-9. PubMed ID: 16296234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute leukemia and pregnancy--fatal fetal outcome after exposure to idarubicin during the second trimester.
    Reynoso EE; Huerta F
    Acta Oncol; 1994; 33(6):709-10. PubMed ID: 7946455
    [No Abstract]   [Full Text] [Related]  

  • 31. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
    Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Successful recovery of an acute myelogenous leukemia patient from a coma possibly due to leukoencephalopathy].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2003 Nov; 44(11):1090-4. PubMed ID: 14689873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].
    Kurahashi S; Iwasaki T; Suzuki H; Sawamoto A; Sugimoto T; Narimatsu H; Adachi T; Hayakawa F; Sugiura I
    Gan To Kagaku Ryoho; 2007 Oct; 34(10):1617-21. PubMed ID: 17940376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.
    Lashkari A; Lowe T; Collisson E; Paquette R; Emmanouilides C; Territo M; Schiller G
    Biol Blood Marrow Transplant; 2006 Apr; 12(4):466-71. PubMed ID: 16545730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A; Falco C; D'Elia R; D'Amico MR; Vicari L; Tambaro FP; Correale P; Laudati D; Palmieri S; Ferrara F
    Eur J Haematol; 2007 Jan; 78(1):41-7. PubMed ID: 17042770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
    Strodtbeck D; Bornhäuser M; Hänel M; Lerche L; Schaich M; Illmer T; Thiede C; Geissler G; Herbst R; Ehninger G; Platzbecker U
    Bone Marrow Transplant; 2005 Dec; 36(12):1083-8. PubMed ID: 16247435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegfilgrastim effectively mobilizes PBSC in a poor mobilizer multiple myeloma patient.
    Malerba L; Mele A; Leopardi G; Stramigioli S; Politi P; Visani G
    Eur J Haematol; 2006 May; 76(5):436-9. PubMed ID: 16480428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imatinib use during pregnancy and breast feeding: a case report and review of the literature.
    Ali R; Ozkalemkas F; Kimya Y; Koksal N; Ozkocaman V; Gulten T; Yorulmaz H; Tunali A
    Arch Gynecol Obstet; 2009 Aug; 280(2):169-75. PubMed ID: 19083009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.